Deep Bio, a leading AI biotech dedicated to cancer diagnosis, and Visiopharm, a world leader in AI-powered image analysis and tissue mining for research and diagnostics, announced a strategic partnership to provide pathologists access to the latest AI-powered prostate cancer solution. AI-powered cancer diagnostics has been proving its utility not only in research, but increasingly […]
The post Deep Bio and Visiopharm announce a collaborative integration of a clinical-grade AI prostate cancer solution with a leading digital pathology platform first appeared on Tissuepathology.com. Reposted from : [#item_link]
Akoya Biosciences Showcases Latest Spatial Biology Innovations at Virtual Spatial Day
January 5, 2023
No Comments
Akoya: New products and partnerships further accelerate and simplify identification of actionable spatial signatures, creating unprecedented opportunities to improve patient outcomes Ready-to-use
